Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q4 2024 Earnings Call ... the uptake of single-uses Zepbound vials increased. We had no wholesaler backorders as we ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

In the US, tirzepatide is sold as Mounjaro for diabetes and under the Zepbound brand for overweight ... but has initially been made available in vials only as Lilly waits for EU approval of ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...

(Reuters) - Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month ...